Europe — EMA
Paderyl (Codeine Phosphate Hemihydrate)
Codeine phosphate, the active ingredient in Paderyl, is an opioid analgesic presented as a tablet for oral use. It is used to treat mild to moderate pain and to suppress cough in adult patients.
Request sourcing
What is Codeine Phosphate Hemihydrate?
Codeine phosphate, the active ingredient in Paderyl, is an opioid analgesic presented as a tablet for oral use. It is used to treat mild to moderate pain and to suppress cough in adult patients. GNH USA supplies Paderyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Paderyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Codeine Phosphate Hemihydrate used for?
Paderyl (codeine phosphate) is an opioid that acts on the central nervous system to relieve pain and reduce coughing.
- Acute pain: Provides relief of mild to moderate pain where stronger opioids are not required. - Cough suppression: Reduces the urge to cough in cases of non‑productive cough. - Diarrhoea management: Slows gastrointestinal motility to help control symptoms of acute diarrhoea.
What are the side effects of Codeine Phosphate Hemihydrate?
Codeine phosphate may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Dizziness - Dry mouth - Light‑headed
Serious or Rare Side Effects: - Respiratory depression - Severe allergic reactions (anaphylaxis) - Dependence or addiction - Withdrawal symptoms on abrupt discontinuation - Low‑t t t t
